NEW

Healthmark Offers New Vendor Credentialing Program

Healthmark Industries’ clinical affairs team has announced the creation of 13 training programs that will be offered for vendors and manufacturer representatives to satisfy vendor credentialing requirements.

Interim Life in the Age of COVID

An interim director of surgical services is familiar with unpredictability. In a new assignment, the needs of the OR, often disparate, compete for their attention. Prioritizing what to execute first is a delicate balancing act.

Asensus Surgical Announces FDA Clearance in General Surgery

Asensus Surgical Inc. (formerly TransEnterix Inc.) has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States. A news release states that Asensus Surgical's technology...

Staying Positive During the Pandemic

The good news for patients in need of outpatient surgery is that, across the country, health care providers and policymakers have recognized that elective surgery is not the same thing as optional surgery and are allowing ASCs to remain open to provide this care.

Study: Surfacide UV-C Light Effective in Pediatric Burn Hospital

A recent study at Shriners Hospitals for Children-Cincinnati, one of only four freestanding hospitals in the country dedicated to the treatment of pediatric burns and specializing in plastic and reconstructive surgery, concluded that the Surfacide Helios UV-C Disinfection System is “… an effective and integral component in reducing bacterial pathogens not killed by the EVS (manual) cleaning process alone.”

The findings were published at the American Burn Association’s 49th Annual Meeting in Boston earlier this year. The authors discussed their findings from 234 cultures obtained from rooms and noted a 37 percent organism reduction from terminal cleaning alone. When the Surfacide UV-C Disinfection System was used in addition to the EVS terminal cleaning process, the authors reported a “total elimination of pathogens.”

“Surfacide’s Helios system incorporates three UV-C energy emitting towers in the patient environment to eradicate drug-resistant organisms, including superbugs such as C. Diff, MRSA, VRE, CRE and Acinetobacter,” said Gunner Lyslo, founder and CEO of Surfacide LLC. “The system has been shown in studies to significantly reduce the risk of HAIs and lower hospital infection rates.”

The 10- to 20-minute Surfacide disinfection cycle is performed in an unoccupied room, after an environmental services cleaning professional has manually cleaned the area and wiped down surfaces. Treating the room with UV-C energy is an evidence-based disinfection modality disinfecting areas that were not completely cleaned manually.

Other systems use a single tower. Surfacide’s multiple emitter approach disinfects an entire room in just one cycle, including the bathroom and other hard-to-reach areas more quickly and effectively. The Helios emitters are positioned closer to hard surfaces, thereby reducing UV-C disinfection time and improving overall efficacy.

Health care providers are turning to UV-C technology as a complement to traditional cleaning methods to combat healthcare-associated infections (HAIs). UV-C energy (at 254nm) is the peak germ-killing part of the ultraviolet spectrum.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X